Insider sale
PASSAGE BIO, INC.
$800.6K
1.29M shares
ORBIMED ADVISORS LLC plans to sell 1.29M shares of PASSAGE BIO, INC. valued at approximately $800.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
IPO
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2020 | IPO N/A | 53.29K | — |
| Total | 53.29K | ||
Completed
Units to sell
127.23K
Market value
$50.9K
Units to sell
57.11K
Market value
$25.1K
Units to sell
50.70K
Market value
$21.8K
Units to sell
23.96K
Market value
$11.5K
Units to sell
11.04K
Market value
$3.8K
Units to sell
213.26K
Market value
$70.4K
Units to sell
138.80K
Market value
$45.8K
Units to sell
231.60K
Market value
$81.1K
Units to sell
68.19K
Market value
$21.8K
Units to sell
89.33K
Market value
$30.4K
Units to sell
78.05K
Market value
$26.5K
Units to sell
77.09K
Market value
$25.4K
Units to sell
61.64K
Market value
$20.3K
Units to sell
10.33K
Market value
$3.9K
Planned — Approximate Date
Units to sell
53.29K
Market value
$361.9K
Units
1.29M
Value
$800.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/10/2025 | 127.23K | $50.9K | — | Completed |
7/9/2025 | 57.11K | $25.1K | — | Completed |
7/8/2025 | 50.70K | $21.8K | — | Completed |
7/7/2025 | 23.96K | $11.5K | — | Completed |
6/27/2025 | 11.04K | $3.8K | — | Completed |
6/26/2025 | 213.26K | $70.4K | — | Completed |
6/25/2025 | 138.80K | $45.8K | — | Completed |
6/24/2025 | 231.60K | $81.1K | — | Completed |
4/24/2025 | 68.19K | $21.8K | — | Completed |
4/23/2025 | 89.33K | $30.4K | — | Completed |
4/22/2025 | 78.05K | $26.5K | — | Completed |
4/17/2025 | 77.09K | $25.4K | — | Completed |
4/16/2025 | 61.64K | $20.3K | — | Completed |
4/15/2025 | 10.33K | $3.9K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2025 | 53.29K | $361.9K | Nasdaq Stock Market | Planned |
| Total | 1.29M | $800.6K | ||